Genentech announced positive results from the Phase III study (REGENCY) of Gazyva (Obinutuzumab) for people with active lupus nephritis (LN).

In a new study, researchers looked to identify unique biomarkers and shared microbial mechanisms among different autoimmune ...

UCB and Biogen have announced positive Phase III clinical trial results for PHOENYCS GO study, evaluating dapirolizumab pegol, a new treatment for moderate-to-severe systemic lupus erythematosus (SLE) ...

In a new study, researchers investigated the prevalence of cardiovascular disease events (CVE) in people with systemic lupus ...

Cullinan Therapeutics has filed an investigational new drug application with the U.S. Food and Drug Administration (FDA) for CLN-978 for the treatment of systemic lupus erythematosus (SLE).

In a recent study, researchers explored the association between HCQ and the overall risk of CV events in people with SLE.

Through clinical trials researchers can test new therapeutic approaches that over time may bring new treatments to people with lupus. Keep up to date with the latest CAR cell research, including ...

The following transcript is automatically generated and may contain typos or misspellings. Please listen to the episode for the most accurate language. Host 0:03 Welcome everyone to the first week of ...

In some people that are photosensitive, UV light from sunlight and indoor light sources can trigger a lupus flare. In addition to sunlight, ultraviolet rays are also given off by several different ...

Nos unimos con Melanie Betz de la American Kidney Fund para responder algunas de las preguntas más frecuentes sobre la dieta y la nutrición al enfrentar complicaciones renales y lupus. La siguiente ...